ArticleMolecular cancer2024

Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation.

Ander Puyalto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.